CircDock6 drives metabolic dysfunction–associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation
Journal of International Medical Research · 2025
DOI: 10.1177/03000605251362984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Medical Research, 2025. Verfasst von Hongpeng Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, China. Hauptthemen laut MEDLINE: RNA, Circular, Hepatocytes, MicroRNAs, Receptor, IGF Type 1. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Zhejiang Provincial.
Abstract (Originalsprache)
Objective
Circular RNAs belong to a category of noncoding RNAs that feature a unique continuous, covalently bonded ring configuration. Recent research indicates that circular RNAs are essential for the development of metabolic dysfunction–associated steatotic liver disease. This study sought to examine the functional role and molecular mechanism of circDock6 in metabolic dysfunction–associated steatotic liver disease.
Methods
Quantitative reverse transcription polymerase chain reaction was performed to determine circDock6 expression patterns in liver tissues from high-fat diet- and standard diet-fed mice in vivo. Triglyceride detection, western blot analysis, and oil red O staining were performed to evaluate the regulatory effect of circDock6 on metabolic dysfunction–associated steatotic liver disease in vitro.
Results
CircDock6 was found to be markedly overexpressed in high-fat diet liver tissues compared with that in standard diet tissues. Moreover, knockdown of circDock6 expression lowered triglyceride content and lipid droplet formation. Mechanistically, circDock6 acted as a molecular sponge for mmu-let-7g-5p, which regulated insulin-like growth factor 1 receptor expression and contributed to the progression of metabolic dysfunction–associated steatotic liver disease. CircDock6 knockdown suppressed metabolic dysfunction–associated steatotic liver disease progression by modulating insulin-like growth factor 1 receptor via mmu-let-7g-5p targeting.
Conclusion
Our study identified circDock6 as a novel regulator of metabolic dysfunction–associated steatotic liver disease pathogenesis through the mmu-let-7g-5p/insulin-like growth factor 1 receptor axis, indicating its potential as a therapeutic target for metabolic dysfunction–associated steatotic liver disease intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, China.
ORCID-Profile: Peifei Li
Förderung
- Natural Science Foundation of Zhejiang Provincial
Zitieren
APA
Lu, H., Ding, X., & Li, P. (2025). CircDock6 drives metabolic dysfunction–associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation. Journal of International Medical Research. https://doi.org/10.1177/03000605251362984
Vancouver
Lu H, Ding X, Li P. CircDock6 drives metabolic dysfunction–associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation. Journal of International Medical Research. 2025. doi:10.1177/03000605251362984
BibTeX
@article{Lu2025,
author = {Lu, Hongpeng and Ding, Xiaoyun and Li, Peifei},
title = {CircDock6 drives metabolic dysfunction–associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation},
journal = {Journal of International Medical Research},
year = {2025},
doi = {10.1177/03000605251362984}
}
EUVIMED